In their research using mouse models of allergy, the authors demonstrated that targeting long-lived plasma cells and preventing memory B cells from class-switching to IgE upon allergen exposure could represent a promising treatment approach for allergic diseases. The gene discussed is IGHE; the disease is allergic disease.